These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16123767)

  • 1. The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia.
    Honey GD; O'loughlin C; Turner DC; Pomarol-Clotet E; Corlett PR; Fletcher PC
    Neuropsychopharmacology; 2006 Feb; 31(2):413-23. PubMed ID: 16123767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task.
    Honey GD; Honey RA; Sharar SR; Turner DC; Pomarol-Clotet E; Kumaran D; Simons JS; Hu X; Rugg MD; Bullmore ET; Fletcher PC
    Psychopharmacology (Berl); 2005 Sep; 181(3):445-57. PubMed ID: 15983801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N; Markou A
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.
    Newcomer JW; Farber NB; Jevtovic-Todorovic V; Selke G; Melson AK; Hershey T; Craft S; Olney JW
    Neuropsychopharmacology; 1999 Feb; 20(2):106-18. PubMed ID: 9885791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an FMRI study.
    Honey RA; Honey GD; O'Loughlin C; Sharar SR; Kumaran D; Bullmore ET; Menon DK; Donovan T; Lupson VC; Bisbrown-Chippendale R; Fletcher PC
    Neuropsychopharmacology; 2004 Jun; 29(6):1203-14. PubMed ID: 15100698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers.
    Parwani A; Weiler MA; Blaxton TA; Warfel D; Hardin M; Frey K; Lahti AC
    Psychopharmacology (Berl); 2005 Dec; 183(3):265-74. PubMed ID: 16220331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle effects of ketamine on memory when administered following stimulus presentation.
    LaPorte DJ; Blaxton TA; Michaelidis T; Robertson DU; Weiler MA; Tamminga CA; Lahti AC
    Psychopharmacology (Berl); 2005 Jul; 180(3):385-90. PubMed ID: 15719220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers.
    Hetem LA; Danion JM; Diemunsch P; Brandt C
    Psychopharmacology (Berl); 2000 Oct; 152(3):283-8. PubMed ID: 11105938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated ketamine administration induces recognition memory impairment together with morphological changes in neurons from ventromedial prefrontal cortex, dorsal striatum, and hippocampus.
    Suárez-Santiago JE; Orozco-Suárez S; Vega-García A; Bautista-Orozco LÁ; Picazo O
    Behav Pharmacol; 2020 Oct; 31(7):633-640. PubMed ID: 32483054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia.
    Evans S; Almahdi B; Sultan P; Sohanpal I; Brandner B; Collier T; Shergill SS; Cregg R; Averbeck BB
    J Psychopharmacol; 2012 Sep; 26(9):1211-7. PubMed ID: 22389244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater vulnerability to the amnestic effects of ketamine in males.
    Morgan CJ; Perry EB; Cho HS; Krystal JH; D'Souza DC
    Psychopharmacology (Berl); 2006 Sep; 187(4):405-14. PubMed ID: 16896964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242.
    Ranganathan M; DeMartinis N; Huguenel B; Gaudreault F; Bednar MM; Shaffer CL; Gupta S; Cahill J; Sherif MA; Mancuso J; Zumpano L; D'Souza DC
    Mol Psychiatry; 2017 Nov; 22(11):1633-1640. PubMed ID: 28242871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
    Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
    Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
    Yurgelun-Todd DA; Renshaw PF; Goldsmith P; Uz T; Macek TA
    Psychopharmacology (Berl); 2020 Feb; 237(2):317-328. PubMed ID: 31773211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.
    Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV
    Neuropsychopharmacology; 2004 Jan; 29(1):208-18. PubMed ID: 14603267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine Enhances Item Novelty Detection via Hippocampal and Associative Recall via Left Lateral Prefrontal Cortex Mechanisms.
    Clos M; Bunzeck N; Sommer T
    J Neurosci; 2019 Oct; 39(40):7920-7933. PubMed ID: 31405927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.